Congress Senators Wyden and Grassley Request Public Comments on Gilead Pricing Thomas Sullivan Jan 27, 2016 0 On the heels of their December 1, 2015, report on Gilead Sciences' pricing of Hepatitis C drugs Sovaldi and Harvoni,…
